Outcomes following initial multicenter experience with robotic aortic valve replacement: Defining a path forward
- PMID: 38246340
- DOI: 10.1016/j.jtcvs.2024.01.020
Outcomes following initial multicenter experience with robotic aortic valve replacement: Defining a path forward
Keywords: RAVR; robotic aortic valve replacement; robotic valve surgery.
Conflict of interest statement
Conflict of Interest Statement Dr Pereda discloses nonfinancial support from Edwards Lifesciences. Dr Melnitchouk discloses consulting fees from Medtronic. Dr Ramzy discloses nonfinancial support from Edwards Lifesciences, Medtronic, and Abbott. Dr Cerny discloses consulting fees from Intuitive Surgical. Dr Smith discloses consulting fees from Edwards Lifesciences, Abbott, Medtronic, and Artivion. Dr Thourani discloses consulting fees from Abbott, Boston Scientific, CryoLife, Edwards Lifesciences, Jenavalve, Medtronic, and Shockwave. All other authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
